Get the latest IDIX - Idenix Pharmaceuticals Inc. stock market performance data and financial news.
Read Jim Cramer's take on Idenix Pharmaceuticals Inc. (IDIX) and get his latest thoughts on the company?s performance and outlook
Get the latest IDIX - Idenix Pharmaceuticals Inc. together with stock market performance data and financial news.
Get the latest IDIX - Idenix Pharmaceuticals Inc. stock market performance data and financial news.
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
Idenix will receive $34 million upfront from Glaxo for drug candidate IDX899, plus up to $416 million in development, regulatory and sales milestones. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10462500/1/glaxo-buys-rights-to-idenix-hiv-drug.html
The company will discontinue its hepatitis B treatment program and instead focus on HCV and HIV.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10381883/1/idenix-pharma-to-cut-tyzeka-jobs.html
Nanogen surges after its first product is approved by the FDA.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10276349/1/todays-health-winners-and-losers.html
Idenix falls on halted drug development.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/newsanalysis/winnershealth/10367850.html
Novartis likes to buy, and the drugmaker might not be through with takeovers.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10261151/1/the-great-swiss-consolidator.html
Connect with TheStreet